News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BofA's Sell Side Indicator rose to 56.0%, implying roughly a 12% S&P 500 price gain over the next 12 months.
  • J.P. Morgan projects gold at $6,300 an ounce by end-2026, citing central-bank purchases and a structural shift toward real assets.
  • U.S. stocks closed lower as technology weakness dragged benchmarks, with markets largely unmoved by the Fed chair nomination.
  • Tyson Foods beat quarterly estimates and raised parts of its fiscal 2026 outlook as stronger chicken sales offset beef losses.
  • Disney beat revenue and profit forecasts on stronger parks results and holiday box-office returns.
  • NHTSA expanded a safety probe to about 1.27 million 2015–2017 Ford F-150s over transmission faults that can cause sudden deceleration or rollaway.
  • ServiceNow reported $3.57B Q4 revenue with 21% growth and strong free cash flow while pushing AI workflow integration.

Latest Articles

ECB at a Crossroads: Five Questions Facing Policymakers as the Euro Strengthens

ECB at a Crossroads: Five Questions Facing Policymakers as the Euro Strengthens

The European Central Bank meets as policymakers weigh the implications of a recent spike in the euro, renewed U.S. trade uncertainty and signs of domestic resilience. With the policy rate likely to remain at 2% for a fifth straight meeting, officials will focus on how exchange-rate moves, energy prices, German fiscal delivery and shifts in U.S. pol…

Goldman Sachs Moves Futu to Buy Citing Strong Client Growth Forecasts

Goldman Sachs Moves Futu to Buy Citing Strong Client Growth Forecasts

Goldman Sachs elevated Futu Holdings Limited (NASDAQ:FUTU) from Neutral to Buy and raised its target price to $213.39 from $157.85, pointing to projected large additions of paying clients in 2026 and 2027 and the company’s high operating efficiency. The bank highlighted Futu’s capacity to expand during favorable market cycles and identified digital…

European Mining Stocks Fall as Gold and Silver Continue Sharp Retreat

European Mining Stocks Fall as Gold and Silver Continue Sharp Retreat

European mining equities opened lower after gold and silver extended steep declines. A firmer dollar, profit-taking and higher margin requirements on COMEX futures amplified selling pressure, pushing spot gold and silver substantially lower and hitting major miners' shares early in the session. Metals remain higher year-to-date despite the recent p…

Morgan Stanley Starts Coverage of Circle With Neutral Rating, Flags Rate Headwinds and Revenue Concentration

Morgan Stanley Starts Coverage of Circle With Neutral Rating, Flags Rate Headwinds and Revenue Concentration

Morgan Stanley began coverage of Circle Internet Group (CRCL) with an Equalweight rating and a $66.00 price target, highlighting a mix of strengths and structural challenges. The bank noted Circle’s USDC stablecoin holds roughly $70 billion in value, but flagged an uncertain regulatory path, reliance on crypto-related use cases, a rate-sensitive in…

Morgan Stanley Lowers Humana Rating, Flags Medicare Advantage Risks

Morgan Stanley Lowers Humana Rating, Flags Medicare Advantage Risks

Morgan Stanley moved Humana from Equalweight to Underweight and reduced its price target to $174 from $262, citing heightened policy risk tied to an unfavorable Advance Rate Notice and uncertainty around Humana's 2026 Medicare Advantage bidding strategy. The new target implies a 9.1x 2027 P/E multiple, below managed care peers at roughly 10.0x. Hum…

Guggenheim Starts Coverage on Cullinan Oncology with Buy, $30 Target

Guggenheim Starts Coverage on Cullinan Oncology with Buy, $30 Target

Guggenheim initiated coverage of Cullinan Oncology Inc. (NASDAQ:CGEM) with a Buy rating and a $30 price target, implying roughly 151% upside from the current share price of $11.96. The firm highlighted CLN-978, a CD19xCD3 bispecific, as the company’s key value driver and pointed to a slate of Phase 1 data readouts across autoimmune indications and …

HSBC Moves Chevron to Hold While Lifting Price Target to $180

HSBC Moves Chevron to Hold While Lifting Price Target to $180

HSBC downgraded Chevron from Buy to Hold while increasing its 12-month price target to $180 from $169. The new target sits marginally above Chevrons recent trading level, reflecting the banks view that the stocks year-to-date rally has tightened upside potential even as the firm maintains a favorable view of Chevrons cash flow trajectory and fi…

JPMorgan Keeps H&M at Underweight, Flags Cost Headwinds Despite Q4 Beat

JPMorgan Keeps H&M at Underweight, Flags Cost Headwinds Despite Q4 Beat

JPMorgan has maintained its Underweight rating and SEK123.00 price target on Hennes & Mauritz AB after the retailer posted a stronger-than-expected fourth-quarter 2025 result. The bank attributes the outperformance mainly to lower operating expenses and a return to more typical writedown levels, but warns these factors may not persist. H&M’s board …

JPMorgan Lowers PTC Rating, Citing Cloud Migration and Competitive Risks

JPMorgan Lowers PTC Rating, Citing Cloud Migration and Competitive Risks

JPMorgan moved PTC Inc. (PTC) from Neutral to Underweight and trimmed its price target to $162 from $205, pointing to difficulties in shifting the company’s legacy Product Lifecycle Management (PLM) and Computer-Aided Design (CAD) products to a cloud-first, Software-as-a-Service model. The call comes as PTC shares trade near $156.13 after a more th…